Evidence map›Paper›PMID 34817797›Full record

ArticleHuman cell2022

Establishment of an immortalized human erythroid cell line sustaining differentiation potential without inducible gene expression system.

Svetlana Soboleva, Ryo Kurita, Naoko Kajitani, Hugo Åkerstrand, Kenichi Miharada

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Blood Pharming of Red Cells.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Svetlana SobolevaDivision of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden.
Ryo KuritaDepartment of Research and Development, Central Blood Institute, Japanese Red Cross Society, Tokyo, Japan.
Naoko KajitaniDivision of Medical Microbiology, Lund University, Lund, Sweden.
Hugo ÅkerstrandDivision of Molecular Hematology, Lund Stem Cell Center, Lund University, Lund, Sweden.
Kenichi MiharadaDivision of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden. kenmiharada@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0001-8073-4001
Lund University · SEJapanese Red Cross Society, Japan · JP

Funding

Cancerfonden 19 0243 PjJapan Society for the Promotion of Science 20K23380Vetenskapsrådet 2018-02738
6 · The paper itself

Abstract

Ex vivo manufactured red blood cells (RBC) generated from immortalized erythroid cell lines which can continuously grow are expected to become a significant alternative in future transfusion therapies. The ectopic expression of human papilloma virus (HPV) E6/E7 gene has successfully been employed to establish these cell lines. To induce differentiation and maturation of the immortalized cell lines, terminating the HPV-E6/E7 expression through a gene induction system has been believed to be essential. Here, we report that erythroid cell lines established from human bone marrow using simple expression of HPV-E6/E7 are capable of normal erythroid differentiation, without turning gene expression off. Through simply changing cell culture conditions, a newly established cell line, Erythroid Line from Lund University (ELLU), is able to differentiate toward mature cells, including enucleated reticulocytes. ELLU is heterogeneous and, unexpectedly, clones expressing adult hemoglobin rapidly differentiate and produce fragile cells. Upon differentiation, other ELLU clones shift from fetal to adult hemoglobin expression, giving rise to more mature cells. Our findings propose that it is not necessary to employ gene induction systems to establish immortalized erythroid cell lines sustaining differentiation potential and describe novel cellular characteristics for desired functionally competent clones.

Indexed as

Cell DifferentiationErythroid CellsGene ExpressionAlphapapillomavirusBone Marrow CellsCell LineClone CellsGenes, ViralGenetic VectorsHemoglobinsHumansReticulocytesHemoglobinsEnucleationHemoglobinHPV-E6/E7Immortalized erythroid cell linesRed blood cells

Identifiers

PMID34817797
OpenAlexW3217777510

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.